Provided by Tiger Trade Technology Pte. Ltd.

iShares Health Innovation Active ETF

32.97
+0.16230.49%
Post-market: 32.96-0.0050-0.02%16:10 EDT
Volume:1K
Turnover:35.22K
Market Cap:13.19M
PE:- -
High:32.98
Open:32.98
Low:32.96
Close:32.80
52wk High:34.86
52wk Low:25.79
Shares:400.00K
Float Shares:400.00K
Volume Ratio:0.45
T/O Rate:0.27%
Dividend:0.08
Dividend Rate:0.25%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 02

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

Dow Jones
·
Sep 02

Merck Files Form 3 for EVP, CIDO Gaurav Gupta

Reuters
·
Sep 02

Rpt: Who: Ervebo Should Only be Used for Bundibugyo Virus (Bvdv) Within the Context of a Research Protocol at This Time

THOMSON REUTERS
·
Sep 01

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Simply Wall St.
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Stoke Therapeutics and Biogen Announce Presentations of Clinical Data from Studies of Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome, at the 16TH European Epilepsy Congress (Eec)

THOMSON REUTERS
·
Sep 01

Satellos to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

Immunic Appoints Chitrang Davé as Chief Data and Digital Officer

Reuters
·
Sep 01

Novartis halts autoimmune CAR-T trials following three deaths, Reuters says

TIPRANKS
·
Sep 01

EDX Medical confirms total voting rights at over 431 million shares

TIPRANKS
·
Sep 01

Zhifei Biological's Freeze-Dried Rabies Vaccine Candidate Receives Clinical Trial Application Acceptance

Stock News
·
Sep 01

Centergate Subsidiary Gains Clinical Trial Clearance for Methylphenidate Prolonged-Release Chewable Tablet

Stock News
·
Sep 01

Novartis Faces Dual Outcomes: CAR-T Halted After Three Deaths While MS Drug Shows Late-Stage Promise

Stock News
·
Sep 01

Celemics inks major U.S. diagnostics licensing and supply deal

TIPRANKS
·
Sep 01

Canada’s Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement of LEQEMBI® (lecanemab) for Early Alzheimer’s Disease

GlobeNewswire
·
Sep 01

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Johnson & Johnson Schedules Investor Call to Discuss Third-Quarter Results

Reuters
·
Sep 01

Biogen, Eisai announce positive recommendation for Leqembi in Canada

TIPRANKS
·
Sep 01

Eisai: Canada's Drug Agency Issues Final Positive Recommendation for Leqembi Reimbursement in Early Alzheimer's Disease

THOMSON REUTERS
·
Sep 01